(INNS)
ULENISTAMAB(INND)
ULENISTAMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS PAUF (PANCREATIC ADENOCARCINOMA UP-REGULATED FACTOR)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-451) [VH (HOMO SAPIENS IGHV1-2*02 (90.8%) -(IGHD) -IGHJ6*01 (90.9%) T123>L (116), CDR-IMGT [8.8.14] (26-33.51- 58.97-110)) (1-121) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (218) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 E12 (360), M14 (362) (345-449), CHS (450-451)) (122-451)], (224- 219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'- 219') [V-KAPPA (HOMO SAPIENS IGKV4-1*01 (91.9%) - IGKJ2*01 (91.7%) L124>V (109), CDR-IMGT [12.3.8] (27-38.56-58.95-102)) (1'-112') -HOMO SAPIENS IGKC*01, KM3 T1.3>S (114), A45.1 (158), V101 (196) (113'-219')]; DIMER (230-230'':233-233'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE, GLYCOFORM ALFA(WHO)
ULENISTAMABUM(INN)